McGillivray Lauren, Keng-Meng Hui Nicholas, Wong Quincy J J, Han Jin, Qian Jiahui, Torok Michelle
Black Dog Institute, University of New South Wales, Sydney, Australia.
Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
JMIR Ment Health. 2023 Mar 30;10:e44862. doi: 10.2196/44862.
Loneliness is commonly reported by young people and has been shown to contribute to the rapid onset and escalation of depression and suicidal ideation during adolescence. Lonely people may also be particularly susceptible to disengaging from treatment early given the likelihood of their more complex clinical profiles leading to cognitive fatigue. While a smartphone intervention (LifeBuoy) has been shown to effectively reduce suicidal ideation in young adults, poor engagement is a well-documented issue for this therapeutic modality and has been shown to result in poorer treatment outcomes.
This study aims to determine whether loneliness affects how young people experiencing suicidal ideation engage with and benefit from a therapeutic smartphone intervention (LifeBuoy).
A total of 455 community-based Australian young adults (aged 18-25 years) experiencing recent suicidal ideation were randomized to use a dialectical behavioral therapy-based smartphone intervention (LifeBuoy) or an attention-matched control app (LifeBuoy-C) for 6 weeks. Participants completed measures of suicidal ideation, depression, anxiety, and loneliness at baseline (T0), post intervention (T1), and 3 months post intervention (T2). Piecewise linear mixed models were used to examine whether loneliness levels moderated the effect of LifeBuoy and LifeBuoy-C on suicidal ideation and depression across time (T0 to T1; T1 to T2). This statistical method was then used to examine whether app engagement (number of modules completed) influenced the relationship between baseline loneliness and suicidal ideation and depression across time.
Loneliness was positively associated with higher levels of overall suicidal ideation (B=0.75, 95% CI 0.08-1.42; P=.03) and depression (B=0.88, 95% CI 0.45-1.32; P<.001), regardless of time point or allocated condition. However, loneliness did not affect suicidal ideation scores across time (time 1: B=1.10, 95% CI -0.25 to 2.46; P=.11; time 2: B=0.43, 95% CI -1.25 to 2.12; P=.61) and depression scores across time (time 1: B=0.00, 95% CI -0.67 to 0.66; P=.99; time 2: B=0.41, 95% CI -0.37 to 1.18; P=.30) in either condition. Similarly, engagement with the LifeBuoy app was not found to moderate the impact of loneliness on suicidal ideation (B=0.00, 95% CI -0.17 to 0.18; P=.98) or depression (B=-0.08, 95% CI -0.19 to 0.03; P=.14).
Loneliness was not found to affect young adults' engagement with a smartphone intervention (LifeBuoy) nor any clinical benefits derived from the intervention. LifeBuoy, in its current form, can effectively engage and treat individuals regardless of how lonely they may be.
Australian New Zealand Clinical Trials Registry ACTRN12619001671156; https://tinyurl.com/yvpvn5n8.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.2196/23655.
年轻人中普遍存在孤独感,且孤独感已被证明会导致青少年期抑郁症和自杀意念迅速发作并加剧。鉴于孤独的人临床情况可能更复杂,容易导致认知疲劳,他们也可能特别容易过早停止治疗。虽然一项智能手机干预措施(救生圈)已被证明能有效减少年轻人的自杀意念,但治疗参与度低是这种治疗方式中一个广为人知的问题,且已证明这会导致较差的治疗效果。
本研究旨在确定孤独感是否会影响有自杀意念的年轻人对一种治疗性智能手机干预措施(救生圈)的参与度以及从中获得的益处。
总共455名有近期自杀意念的澳大利亚社区年轻人(年龄在18 - 25岁之间)被随机分配使用基于辩证行为疗法的智能手机干预措施(救生圈)或注意力匹配的对照应用程序(救生圈 - C),为期6周。参与者在基线(T0)、干预后(T1)和干预后3个月(T2)完成了自杀意念、抑郁、焦虑和孤独感的测量。采用分段线性混合模型来检验孤独感水平是否调节了救生圈和救生圈 - C在不同时间(T0至T1;T1至T2)对自杀意念和抑郁的影响。然后使用这种统计方法来检验应用程序参与度(完成的模块数量)是否影响基线孤独感与不同时间的自杀意念和抑郁之间的关系。
无论时间点或分配的条件如何,孤独感与更高水平的总体自杀意念(B = 0.75,95%CI 0.08 - 1.42;P = 0.03)和抑郁(B = 0.88,95%CI 0.45 - 1.32;P < 0.001)呈正相关。然而,孤独感在任何一种情况下均未影响不同时间的自杀意念得分(时间1:B = 1.10,95%CI - 0.25至2.46;P = 0.11;时间2:B = 0.43,95%CI - 1.25至2.12;P = 0.61)和不同时间的抑郁得分(时间1:B = 0.00,95%CI - 0.67至0.66;P = 0.99;时间2:B = 0.41,95%CI - 0.37至1.18;P = 0.30)。同样,未发现使用救生圈应用程序会调节孤独感对自杀意念(B = 0.00,95%CI - 0.17至0.18;P = 0.98)或抑郁(B = - 0.08,95%CI - 0.19至0.03;P = 0.14)的影响。
未发现孤独感会影响年轻人对智能手机干预措施(救生圈)的参与度,也未影响该干预措施带来的任何临床益处。目前形式的救生圈能够有效地让个体参与并进行治疗,无论他们有多孤独。
澳大利亚和新西兰临床试验注册中心ACTRN12619001671156;https://tinyurl.com/yvpvn5n8。
国际注册报告识别号(IRRID):RR2 - 10.2196/23655。